These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36999423)

  • 21. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.
    Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM
    J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus:
    Kurnia D; Wiani I; Zainuddin A; Windaryanti D; Sondang Gabriel C
    Comb Chem High Throughput Screen; 2023; 26(2):383-391. PubMed ID: 35538835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex.
    Bhardwaj A; Sharma S; Singh SK
    Turk J Pharm Sci; 2022 Feb; 19(1):93-100. PubMed ID: 35227055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soybean-associated endophytic fungi as potential source for anti-COVID-19 metabolites supported by docking analysis.
    El-Hawary SS; Mohammed R; Bahr HS; Attia EZ; El-Katatny MH; Abelyan N; Al-Sanea MM; Moawad AS; Abdelmohsen UR
    J Appl Microbiol; 2021 Sep; 131(3):1193-1211. PubMed ID: 33559270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computer-Aided Drug Discovery Approaches in the Identification of Anticancer Drugs from Natural Products: A Review.
    Priya MGR; Manisha J; M L LP; Rathore SS; Viswas RS
    Curr Comput Aided Drug Des; 2024 May; ():. PubMed ID: 38698753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Silico Identification of New Anti-SARS-CoV-2 Main Protease (M
    Onyango H; Odhiambo P; Angwenyi D; Okoth P
    J Trop Med; 2022; 2022():3697498. PubMed ID: 36263438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.
    Hossain R; Sarkar C; Hassan SMH; Khan RA; Arman M; Ray P; Islam MT; Daştan SD; Sharifi-Rad J; Almarhoon ZM; Martorell M; Setzer WN; Calina D
    Chin J Integr Med; 2022 Mar; 28(3):249-256. PubMed ID: 34913151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment.
    Naik B; Gupta N; Ojha R; Singh S; Prajapati VK; Prusty D
    Int J Biol Macromol; 2020 Oct; 160():1-17. PubMed ID: 32470577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus
    Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
    Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling.
    Balogun TA; Chukwudozie OS; Ogbodo UC; Junaid IO; Sunday OA; Ige OM; Aborode AT; Akintayo AD; Oluwarotimi EA; Oluwafemi IO; Saibu OA; Chuckwuemaka P; Omoboyowa DA; Alausa AO; Atasie NH; Ilesanmi A; Dairo G; Tiamiyu ZA; Batiha GE; Alkhuriji AF; Al-Megrin WAI; De Waard M; Sabatier JM
    Front Chem; 2022; 10():964446. PubMed ID: 36304744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Butein as a potential binder of human ACE2 receptor for interfering with SARS-CoV-2 entry: a computer-aided analysis.
    Kapoor N; Ghorai SM; Khuswaha PK; Bandichhor R; Brogi S
    J Mol Model; 2022 Aug; 28(9):270. PubMed ID: 36001177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico approach for identifying natural lead molecules against SARS-COV-2.
    Gupta SS; Kumar A; Shankar R; Sharma U
    J Mol Graph Model; 2021 Jul; 106():107916. PubMed ID: 33892297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
    Di Paola L; Hadi-Alijanvand H; Song X; Hu G; Giuliani A
    J Proteome Res; 2020 Nov; 19(11):4576-4586. PubMed ID: 32551648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M
    Piplani S; Singh P; Petrovsky N; Winkler DA
    Front Mol Biosci; 2022; 9():781039. PubMed ID: 35359601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.